Aptorum Group shareholders approve merger with DiamiR Biosciences Jun 10, 2026 08:04AM
Aptorum Group and DiamiR publish glioblastoma biomarker study Mar 10, 2026 08:05AM
DiamiR and INB collaborate to validate APOE testing platform Feb 2, 2026 08:03AM
DiamiR and Aptorum Group present alzheimer's research at CTAD conference Nov 19, 2025 08:03AM
Aptorum Group adds Dr. Laura Philips to board ahead of DiamiR merger Oct 9, 2025 08:55AM


Jul 16, 2025 08:38AM Aptorum Group agrees to acquire DiamiR Biosciences in all-stock merger
Apr 16, 2025 12:29PM Aptorum Group Ltd. (APM) receives minimum price deficiency notification from Nasdaq
Jan 2, 2025 11:02AM Aptorum Group Ltd. (APM) Prices 1.54M Share IPO at $2/sh